1. Home
  2. NTIC vs ATYR Comparison

NTIC vs ATYR Comparison

Compare NTIC & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northern Technologies International Corporation

NTIC

Northern Technologies International Corporation

N/A

Current Price

$8.71

Market Cap

83.1M

Sector

Industrials

ML Signal

N/A

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.83

Market Cap

69.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTIC
ATYR
Founded
1970
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.1M
69.2M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
NTIC
ATYR
Price
$8.71
$0.83
Analyst Decision
Hold
Analyst Count
0
8
Target Price
N/A
$4.20
AVG Volume (30 Days)
3.9K
1.5M
Earning Date
04-24-2026
01-01-0001
Dividend Yield
0.46%
N/A
EPS Growth
N/A
N/A
EPS
0.03
N/A
Revenue
$84,234,474.00
N/A
Revenue This Year
$11.40
N/A
Revenue Next Year
$8.70
$18,728.62
P/E Ratio
$294.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.77
$0.64
52 Week High
$11.60
$7.29

Technical Indicators

Market Signals
Indicator
NTIC
ATYR
Relative Strength Index (RSI) 45.91 41.02
Support Level $8.55 $0.67
Resistance Level $9.48 $0.85
Average True Range (ATR) 0.28 0.08
MACD -0.05 -0.02
Stochastic Oscillator 16.15 2.38

Price Performance

Historical Comparison
NTIC
ATYR

About NTIC Northern Technologies International Corporation

Northern Technologies International Corp is a United States-based firm that develops and markets proprietary, environmentally beneficial products and services world wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments, which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company. The company generates the majority of its revenue in the United States.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: